Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
+7.68M
-
Total reported value, excl. options
-
$184M
-
Value change
-
+$77.9M
-
Put/Call ratio
-
0.3
-
Number of buys
-
33
-
Number of sells
-
-28
-
Price
-
$9.25
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q4 2022
74 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q4 2022.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 96M outstanding shares and own 20.7% of the company stock.
Largest 10 shareholders include Lynx1 Capital Management LP (2.83M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.54M shares), Cormorant Asset Management, LP (1.97M shares), VR Adviser, LLC (1.9M shares), BAKER BROS. ADVISORS LP (1.34M shares), Blackstone Inc. (1.25M shares), COMMODORE CAPITAL LP (1.01M shares), VANGUARD GROUP INC (929K shares), FRED ALGER MANAGEMENT, LLC (736K shares), and Boxer Capital, LLC (540K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.